Amanda Itzkoff, MD

New York City NY
Dr. Itzkoff provides a caring, warm, nonjudgmental environment. Dr. Itzkoff’s private practice is distinguished as a setting in which she can work with each patient to understand their unique concerns, their individual goals, and their personal beliefs, and through a collaborative process, ensure that these are reflected in each patient’s treatment design and throughout the ongoing, collaborative care. Dr. Itzkoff offers the full spectrum of psychiatric treatment options available, including psychotherapy, also known as “talk therapy,” as well as psychopharmacology, which involves administration of medications designed to modify behavior or moods. While some patients are treated with both talk therapy and medication, others are treated with a focus on one or the other treatment modality alone. Board certified in psychiatry, Dr. Amanda Itzkoff is thoroughly trained in the most modern applications of both treatment approaches.
Dr. Amanda Itzkoff, MD is trained to use both medication and talk therapy to treat all psychiatric disorders including depression, anxiety, bipolar disorder, substance abuse and dependence, reproductive psychiatry, and eating disorders. Dr. Amanda Itzkoff offers a full spectrum of services including psychotherapy, psychopharmacology, and interventional treatment including dTMS and ketamine for eligible patients with treatment-resistant conditions. Buprenorphine to treat addiction is available. All patients are treated in a non-judgmental, warm, and strictly confidential environment. Dr. Itzkoff completed undergraduate education at Cornell where she was valedictorian. She then attended NYU School of Medicine and completed the Mount Sinai Residency Training program in Psychiatry as well as a Mount Sinai Fellowship. She remains on Faculty at Mount Sinai. Dr. Itzkoff was also selected as the winner of the Adele Zinbeg Award for Women’s Leadership in Psychiatry. Dr. Amanda Itzkoff provides each person with personalized treatment for his or her own goals. Treatments range from psychotherapy to ketamine infusion to dTMS, which is a form of transcranial magnetic stimulation, FDA cleared for the treatment of depression and OCD.